REFERENCE TITLE: preauthorization prohibition; addiction medications State of Arizona House of Representatives Fifty-seventh Legislature First Regular Session 2025 HB 2674 Introduced by Representative Blackman AN ACT amending title 36, chapter 29, article 1, arizona revised statutes, by adding section 36-2907.16; relating to the Arizona health care cost containment system. (TEXT OF BILL BEGINS ON NEXT PAGE)
REFERENCE TITLE: preauthorization prohibition; addiction medications
State of Arizona House of Representatives Fifty-seventh Legislature First Regular Session 2025
HB 2674
Introduced by Representative Blackman
REFERENCE TITLE: preauthorization prohibition; addiction medications
State of Arizona
House of Representatives
Fifty-seventh Legislature
First Regular Session
2025
HB 2674
Introduced by
Representative Blackman
AN ACT
amending title 36, chapter 29, article 1, arizona revised statutes, by adding section 36-2907.16; relating to the Arizona health care cost containment system.
(TEXT OF BILL BEGINS ON NEXT PAGE)
Be it enacted by the Legislature of the State of Arizona: Section 1. Title 36, chapter 29, article 1, Arizona Revised Statutes, is amended by adding section 36-2907.16, to read: START_STATUTE36-2907.16. Preauthorization; step edit requirements; prohibition; medications; opioid use disorder Beginning on October 1, 2026, the administration and its contractors may not impose any preauthorization requirement or step edit requirement for any form or formulation of any United States food and drug administration-approved medication for the treatment of opioid use disorder. END_STATUTE
Be it enacted by the Legislature of the State of Arizona:
Section 1. Title 36, chapter 29, article 1, Arizona Revised Statutes, is amended by adding section 36-2907.16, to read:
START_STATUTE36-2907.16. Preauthorization; step edit requirements; prohibition; medications; opioid use disorder
Beginning on October 1, 2026, the administration and its contractors may not impose any preauthorization requirement or step edit requirement for any form or formulation of any United States food and drug administration-approved medication for the treatment of opioid use disorder. END_STATUTE